AbbVie 2012 Annual Report Download - page 137

Other 2012 Goals
Richard A. Gonzalez
Execute commercial plan and product enhancements for key brands; secure key strategic high
quality pipeline assets for sourced innovation by the end of 2012, either in-licensed products or business
acquisitions; advance existing pipeline assets by achieving key milestones; implement a comprehensive
set of actions to increase pipeline probability of success and internal rate of return; achieve separation
into an independent publicly-traded pharmaceutical company by the end of 2012; meet key talent
attraction and retention targets; create and implement organizational design of new Strategic Projects
Office and Transition Office functions by the date of Company separation.
Results: Mr. Gonzalez achieved the above goals in all material aspects.
Laura J. Schumacher
Successfully resolve key litigation matters; achieve proprietary pharmaceutical pipeline
enhancement objectives; execute separation of Abbott into two independent companies by the end of
2012; achieve key compliance initiatives.
Results: Ms. Schumacher achieved the above goals in all material aspects.
William J. Chase
Achieve proprietary pharmaceutical pipeline enhancement objectives; achieve emerging markets
goals; achieve device pipeline long-range plan enhancement goals; resolve in-process negotiations and
execute due diligence activities.
Results: Mr. Chase achieved the above goals in all material aspects.
Carlos Alban
Achieve key product milestones; implement patient support programs by December 2012; execute
market development activities; secure key strategic high quality pipeline assets for sourced innovation
by the end of 2012; achieve separation into a publicly-traded pharmaceutical company by the end of
2012; develop and execute strategic initiatives in response to changing healthcare environment; create
innovative and differential development opportunities for top talent; meet internal and external talent
objectives.
Results: Mr. Alban achieved the above goals in all material aspects.
John M. Leonard, M.D.
Ensure creation of required organizational structure to support a publicly-traded independent
company; support key activities to ensure appropriate separation of affiliate structures; evaluate critical
business processes required to support separation; secure key strategic high quality pipeline assets for
sourced innovation by the end of 2012; advance existing pipeline assets by achieving key milestones;
enhance research and development innovation and effectiveness.
Results: Mr. Leonard mostly achieved the above goals in all material aspects.
Goal Performance and 2012 Compensation Decisions
The individual goals described above were determined at the beginning of 2012 as part of Abbott’s
annual performance and compensation planning process. Abbott considered, at both the company and
individual levels, achievement with respect to these goals, as well as the performance of the individual
overall with respect to all matters not specifically defined in the pre-determined goals, including
23